Computerized matching of autologous femoral grafts for the treatment of medial talar osteochondral defects

Good clinical and functional outcomes at mid-term following autologous osteochondral transplantation for osteochondral lesions of the talus

PURPOSE

Autologous osteochondral transplantation is an established treatment for large-sized osteochondral lesions of the talus (OLT) with excellent short term outcomes. However, few studies assess the outcomes of autologous osteochondral transplantation at mid-term follow-up. The purpose of the current systematic review was to evaluate the clinical outcomes of the autologous osteochondral transplantation procedure in the treatment of OLT at mid-term and long-term follow-up.

METHODS

A systematic search of the MEDLINE, EMBASE and Cochrane Library databases was performed in October 2017 based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Included studies were evaluated with regard to level of evidence (LOE) and quality of evidence (QOE) using the Coleman Methodology Score. Clinical outcomes, and complications were also evaluated.

RESULTS

Eleven studies, with 500 ankles were included at a mean 62.8 months follow-up. Seven studies used the American Orthopaedic Foot and Ankle Society (AOFAS) score. The weighted mean preoperative AOFAS score was 55.1 ± 6.1, and the postoperative score was 86.2 ± 4.5, with 87.4% of patients (132 of 151) being reported as excellent or good results. In total, 53 of the 500 patients (10.6%) had complications. The most common complication was donor site morbidity with 18 patients (3.6%) at final follow-up. Thirty-one patients (6.2%) underwent reoperations, and 5 ankles (1.0%) were regarded as failed autologous osteochondral transplantation.

CONCLUSION

The current systematic review demonstrated that good clinical and functional outcomes can be expected following autologous osteochondral transplantation for the treatment of OLT, with a low failure rate. The results from this study show patients can be reasonably counselled to expect good clinical outcomes in the mid-term. MRI and radiographs showed restoration of articular surface as well as a minimal presence of osteoarthritis at mid-term follow-up. However, as low level and quality of evidence and the variability of the data may confound the data, further well-designed studies are necessary to determine the effectiveness of autologous osteochondral transplantation in the treatment for OLT.

LEVEL OF EVIDENCE

IV.

Autologous osteochondral transplantation for osteochondral lesions of the talus in an athletic population

PURPOSE

To assess clinical outcomes and return to sport in an athletic population treated with autologous osteochondral transplantation (AOT) for osteochondral lesions of the talus.

METHODS

A total of 36 patients were included in this retrospective study including 21 professional athletes and 15 amateur athletes who participated in regular moderate- or high-impact athletic activity. All patients underwent autologous osteochondral transplantation of the talus under the care of a single surgeon. At a mean follow-up of 5.9 years, patients were assessed using the American Orthopaedic Foot and Ankle Society (AOFAS) scoring system. All patients also received pre-operative MRI with the follow-up MRI performed at 1 year and underwent assessment of return to athletic activity.

RESULTS

The overall AOFAS score improved from 65.5 (SD ± 11.1) to 89.4 (SD ± 14.4) (p = 0.01). At a final follow-up, 90% of professional athletes (19 of 21) were still competing in athletic activity or still able to participate in unrestricted activity. Of the recreational athletes, 87% (13 of 15) had full return to pre-injury activity levels, while two (13%) returned to activity with restrictions or reduced intensity. MRI showed cystic change in 33% of patients post-operatively; however, this did not appear to affect outcomes (n.s.). Donor site symptoms were seen in 11% of the cohort at final follow-up, despite high function at donor knee.

CONCLUSION

The results of our study indicate that AOT procedure is able to achieve good outcomes in an athletic population at a midterm follow-up.

LEVEL OF EVIDENCE

Retrospective case series, Level IV.

The use of allograft in joint-preserving surgery for ankle osteochondral lesions and osteoarthritis

The surgical management of young patients with large osteochondral lesions of the talus or end-stage osteoarthritis of the ankle joint presents a challenge to the orthopedic surgeon because these are well-recognized sources of pain and dysfunction. Procedures designed to address these disorders either have a limited role because of poor success rates or have significant implications, such as with the total ankle arthroplasty. Fresh osteochondral allografts allow defective tissue to be anatomically matched and reconstructed through transplantation. This article presents an overview of fresh osteochondral allografts, as well as potential concerns with their use, and summarizes the current literature.

Mapping of cartilage depth in the knee and elbow for use in osteochondral autograft procedures

BACKGROUND

Osteochondritis dissecans (OCD) of the elbow is a problematic condition that affects a fair number of young athletes. One treatment option is the use of osteochondral autografts, which are commonly taken from donor sites on the less weightbearing surfaces of the knee.

PURPOSE

To use magnetic resonance imaging (MRI) to assess the cartilage depths of sites in the knee and elbow that are commonly used as donor and recipient sites to optimize depth matching for osteochondral autograft procedures.

STUDY DESIGN

Descriptive laboratory study.

METHODS

All knee and elbow MRI scans acquired from 3-T machines in patients aged 16 to 25 years within a single hospital system were reviewed. Studies were excluded if there had been previous surgery on the joint or if there were significant chondral defects in the areas to be measured. All cartilage depth measurements were independently performed by 3 different physicians to the nearest 0.01 mm. At the elbow, 6 locations on the capitellum and 2 on the trochlea were chosen. At the knee, 4 locations along the anterior-lateral femoral condyle, 5 surrounding the intercondylar notch, and 1 on both the medial- and lateral-posterior femoral condyles were chosen.

RESULTS

There were 111 knee MRI (74 male, 37 female) and 94 elbow MRI (85 male, 9 female) scans that met all inclusion criteria. The average cartilage depths from each investigator were then averaged to provide an overall mean depth at each location. All average cartilage depths within the knee were thicker than those in the elbow, where the averaged mean thickness of all the 8 measured sites was 1.27 mm (range, 0.78-1.63 mm). Within the knee, the thinnest areas of cartilage, and therefore closest matches, were discovered at the posterior pole of the medial femoral condyle (mean ± SD, 1.95 ± 0.46 mm) and at the distal-most anterior-lateral femoral condyle (1.85 ± 0.46 mm). The average variance between the mean cartilage depths measured by each investigator for each location was 0.12 mm in the elbow and 0.22 mm in the knee.

CONCLUSION

Average cartilage depths in the knee were thicker than those in the elbow at all sites measured. The thinnest areas in the knee were the posterior aspect of the medial femoral condyle and the distal-most aspect of the anterior-lateral femoral condyle.

CLINICAL RELEVANCE

This study provides the surgeon with meaningful data on average cartilage depths at common donor sites in the knee and recipient sites in the elbow.

Automated planning of computer assisted mosaic arthroplasty

We describe and evaluate a computer algorithm that automatically develops a surgical plan for computer assisted mosaic arthroplasty, a technically demanding procedure in which a set of osteochondral plugs are transplanted from a non-load-bearing area of the joint to the site of a cartilage defect. We found that the algorithm produced plans that were at least as good as a human expert, had less variability, and took less time.